Ravenquest Financial Statements From 2010 to 2024
Ravenquest Biomed financial statements provide useful quarterly and yearly information to potential Ravenquest Biomed investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ravenquest Biomed financial statements helps investors assess Ravenquest Biomed's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ravenquest Biomed's valuation are summarized below:Ravenquest Biomed does not presently have any trending fundamental ratios for analysis.
This module can also supplement various Ravenquest Biomed Technical models . Check out the analysis of Ravenquest Biomed Correlation against competitors.
Check Ravenquest Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ravenquest Biomed's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ravenquest financial statements analysis is a perfect complement when working with Ravenquest Biomed Valuation or Volatility modules.
Ravenquest |
Ravenquest Biomed Company Return On Equity Analysis
Ravenquest Biomed's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Ravenquest Biomed Return On Equity | -1.12 |
Most of Ravenquest Biomed's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ravenquest Biomed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Ravenquest Biomed has a Return On Equity of -1.1246. This is 95.31% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Ravenquest Biomed Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ravenquest Biomed's current stock value. Our valuation model uses many indicators to compare Ravenquest Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ravenquest Biomed competition to find correlations between indicators driving Ravenquest Biomed's intrinsic value. More Info.Ravenquest Biomed is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ravenquest Biomed's earnings, one of the primary drivers of an investment's value.About Ravenquest Biomed Financial Statements
Ravenquest Biomed stakeholders use historical fundamental indicators, such as Ravenquest Biomed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ravenquest Biomed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ravenquest Biomed's assets and liabilities are reflected in the revenues and expenses on Ravenquest Biomed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ravenquest Biomed. Please read more on our technical analysis and fundamental analysis pages.
RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Ravenquest Pink Sheet
Ravenquest Biomed financial ratios help investors to determine whether Ravenquest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ravenquest with respect to the benefits of owning Ravenquest Biomed security.